{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:13:10Z","timestamp":1783437190533,"version":"3.54.6"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81302784"],"award-info":[{"award-number":["81302784"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673444"],"award-info":[{"award-number":["81673444"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009558","name":"University Natural Science Research Project of Anhui Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009558","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010012","name":"National Aerospace Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010012","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.intimp.2020.106199","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T06:08:35Z","timestamp":1579154915000},"page":"106199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Alleviating effect of paeoniflorin-6\u2032-O-benzene sulfonate in antigen-induced experimental Sj\u00f6gren\u2019s syndrome by modulating B lymphocyte migration via CXCR5-GRK2-ERK\/p38 signaling pathway"],"prefix":"10.1016","volume":"80","author":[{"given":"Xiaoyun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaolin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"K\u00f6rner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2020.106199_b0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.clim.2019.04.009","article-title":"Sjogren's syndrome: an update on disease pathogenesis, clinical manifestations and treatment","volume":"203","author":"Vivino","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2020.106199_b0010","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/BOR.0000000000000473","article-title":"Current views on the pathogenesis of Sj\u00f6gren's syndrome","volume":"30","author":"Pontarini","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.intimp.2020.106199_b0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1741-7015-11-93","article-title":"Novel aspects of sj\u00f6gren\u2019s syndrome in 2012","volume":"11","author":"Tincani","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.intimp.2020.106199_b0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jbspin.2017.06.004","article-title":"Efficacy and safety of biological dmards modulating B cells in primary Sj\u00f6gren's syndrome: systematic review and meta-analysis","volume":"85","author":"Letaief","year":"2018","journal-title":"Joint Bone Spine."},{"key":"10.1016\/j.intimp.2020.106199_b0025","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/ard.2008.096172","article-title":"Is the blood B-cell subset profile diagnostic for Sj\u00f6gren\u2019s syndrome","volume":"68","author":"Binard","year":"2009","journal-title":"Annals Rheumat. Diseases"},{"key":"10.1016\/j.intimp.2020.106199_b0030","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/art.21129","article-title":"Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"52","author":"Hansen","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2020.106199_b0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrrheum.2016.217","article-title":"Ectopic lymphoid neogenesis in rheumatic autoimmune diseases","volume":"13","author":"Bombardieri","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2020.106199_b0040","first-page":"1860","article-title":"Increased expression of CXCR5 and CXCL13 in mice with experimental autoimmune myocarditis","volume":"21","author":"Han","year":"2017","journal-title":"Eur. Rev. Med. Pharmaco. Sci."},{"key":"10.1016\/j.intimp.2020.106199_b0045","first-page":"191","article-title":"Ectopic expression of the B cell\u2013attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center\u2013like structures in Sj\u00f6gren's syndrome","volume":"1","author":"Amft","year":"2016","journal-title":"Arthritis Rheumat."},{"key":"10.1016\/j.intimp.2020.106199_b0050","article-title":"Retinoic acid-induced blr1 expression promotes ERK2 activation and cell differentiation in HL-60 cells","volume":"254","author":"Battle","year":"2002","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.intimp.2020.106199_b0055","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0092-8674(00)81798-5","article-title":"A putative chemokine receptor, blr1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen","volume":"87","author":"F\u00f6rster","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2020.106199_b0060","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1515\/BC.2001.171","article-title":"Signal transduction by the chemokine receptor CXCR5: structural requirements for G protein activation analyzed by chimeric CXCR1\/CXCR5 molecules","volume":"382","author":"M\u00fcller","year":"2001","journal-title":"Biol. Chem."},{"key":"10.1016\/j.intimp.2020.106199_b0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1742-2094-6-42","article-title":"The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis","volume":"6","author":"Rupprecht","year":"2009","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.intimp.2020.106199_b0070","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13075-018-1611-2","article-title":"Role of CXCL13 and CCL20 in the recruitment of B cells to inflammatory foci in chronic arthritis","volume":"20","author":"Armas-Gonz\u00e1lez","year":"2018","journal-title":"Arthritis Res. Therapy"},{"key":"10.1016\/j.intimp.2020.106199_b0075","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1189\/jlb.0113036","article-title":"CXCL13 is elevated in Sj\u00f6gren's syndrome in mice and humans and is implicated in disease pathogenesis","volume":"94","author":"Kramer","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2020.106199_b0080","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s10067-018-4153-8","article-title":"Advances in the diagnosis and treatment of Sj\u00f6gren's syndrome","volume":"37","author":"Chen","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.intimp.2020.106199_b0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/1759720X17746319","article-title":"Management of primary Sj\u00f6gren's syndrome: recent developments and new classification criteria","volume":"10","author":"Del Papa","year":"2018","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.intimp.2020.106199_b0090","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/bjd.16442","article-title":"Pilocarpine and Artificial Saliva for the Treatment of Xerostomia and Xerophthalmia of Sj\u00f6gren's Syndrome: a double blind control trial","volume":"179","author":"Cifuentes","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.intimp.2020.106199_b0095","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.rdc.2016.03.010","article-title":"New treatment guidelines for Sj\u00f6gren's Disease","volume":"42","author":"Vivino","year":"2016","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.intimp.2020.106199_b0100","doi-asserted-by":"crossref","unstructured":"Demarchi, S. Papasidero, M.A. Medina, D. Klajn, R. Chaparro Del Moral, O. Rillo et al. Primary Sj\u00f6gren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy, Clin. Rheumatol. 36 (2017) 2455\u20132460.","DOI":"10.1007\/s10067-017-3822-3"},{"key":"10.1016\/j.intimp.2020.106199_b0105","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s10067-015-3050-7","article-title":"Pregnancy outcome of 126 anti-SSA\/Ro-positive patients during the past 24 years\u2013a retrospective cohort study","volume":"34","author":"Luo","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.intimp.2020.106199_b0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7150\/ijms.17718","article-title":"Reviewing primary Sj\u00f6gren\u2019s syndrome: Beyond the dryness - from pathophysiology to diagnosis and treatment","volume":"14","author":"Both","year":"2017","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.intimp.2020.106199_b0115","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cellimm.2012.12.005","article-title":"Total glucosides of paeony inhibits th1\/th17 cells via decreasing dendritic cells activation in rheumatoid arthritis","volume":"280","author":"Lin","year":"2012","journal-title":"Cell Immunol."},{"key":"10.1016\/j.intimp.2020.106199_b0120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.intimp.2016.08.006","article-title":"Clinical and immunological consequences of total glucosides of paeony treatment in Sj\u00f6gren's syndrome: A randomized controlled pilot trial","volume":"39","author":"Zhou","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2020.106199_b0125","article-title":"Pharmacokinetic comparisons of paeoniflorin and paeoniflorin-6\u201co-benzene sulfonate in rats via different routes of administration","volume":"1\u20139","author":"Wang","year":"2016","journal-title":"Xenobiotica"},{"key":"10.1016\/j.intimp.2020.106199_b0130","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3389\/fphar.2018.00563","article-title":"A modified compound from paeoniflorin, CP-25, suppressed immune responses and synovium inflammation in collagen-induced arthritis mice","volume":"9","author":"Chen","year":"2018","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.intimp.2020.106199_b0135","doi-asserted-by":"crossref","first-page":"26239","DOI":"10.1038\/srep26239","article-title":"CP-25, a novel compound, protects against autoimmune arthritis by modulating immune mediators of inflammation and bone damage","volume":"6","author":"Chang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2020.106199_b0140","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/bcpt.13025","article-title":"CP-25 Alleviates Experimental Sj\u00f6gren\u2019s Syndrome Features in NOD\/Ltj Mice and Modulates T Lymphocyte Subsets","volume":"9","author":"Gu","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.intimp.2020.106199_b0145","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/s41401-018-0196-2","article-title":"CP-25 reverses prostaglandin E4 receptor desensitization-induced fibroblast-like synoviocyte dysfunction via the G protein-coupled receptor kinase 2 in autoimmune arthritis","volume":"40","author":"Jia","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2020.106199_b0150","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.biopha.2018.12.040","article-title":"CP-25 combined with MTX\/ LEF ameliorates the progression of adjuvant induced arthritis by the inhibition on GRK2 translocation","volume":"110","author":"Yang","year":"2019","journal-title":"Biomed Pharmacother."},{"key":"10.1016\/j.intimp.2020.106199_b0155","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/jcp.23.8.690","article-title":"Lymphocytic sialadenitis in the major and minor glands: a correlation in postmortem subjects","volume":"23","author":"Chisholm","year":"1970","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.intimp.2020.106199_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03009742.2017.1324909","article-title":"Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sj\u00f6gren\u2019s syndrome (secondary Sj\u00f6gren\u2019s syndrome) focusing on autoimmune rheumatic diseases","volume":"47","author":"Alani","year":"2018","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.intimp.2020.106199_b0165","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/mi.2012.66","article-title":"Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury","volume":"6","author":"Eickmeier","year":"2013","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.intimp.2020.106199_b0170","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/annrheumdis-2013-204584","article-title":"Th17 cells play a critical role in the development of experimental Sj\u00f6gren's syndrome","volume":"4","author":"Lin","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2020.106199_b0175","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/art.40500","article-title":"Interleukin-25 Axis Is Involved in the Pathogenesis of Human Primary and Experimental Murine Sj\u00f6gren's Syndrome","volume":"70","author":"Guggino","year":"2018","journal-title":"Arthritis. Rheumatol."},{"key":"10.1016\/j.intimp.2020.106199_b0180","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jep.2007.08.014","article-title":"Preventive effect of Ophiopogon japonicus polysaccharides on an autoallergic mouse model for Sjogren's syndrome by regulating the Th1\/Th2 cytokine imbalance","volume":"114","author":"Wang","year":"2007","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2020.106199_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00296-018-4018-0","article-title":"Association between memory B-cells and clinical and immunological features of primary Sj\u00f6gren\u2019s syndrome and Sicca patients","volume":"38","author":"Barcelos","year":"2018","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.intimp.2020.106199_b0190","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.4049\/jimmunol.167.7.3610","article-title":"Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sj\u00f6gren's syndrome","volume":"167","author":"Bohnhorst","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2020.106199_b0195","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/art.20276","article-title":"Abnormalities in peripheral B cell memory of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"50","author":"Hansen","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2020.106199_b0200","doi-asserted-by":"crossref","unstructured":"Ga\u00ebtane Nocturne, X. Mariette. B cells in the pathogenesis of primary Sj\u00f6gren syndrome. Nature Rev. Rheumatol., vol. 14, 2018.","DOI":"10.1038\/nrrheum.2018.1"},{"key":"10.1016\/j.intimp.2020.106199_b0205","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1002\/art.10445","article-title":"Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sj\u00f6gren's syndrome","volume":"46","author":"Hansen","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2020.106199_b0210","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nri1786","article-title":"Lymphoid neogenesis in chronic inflammatory diseases","volume":"6","author":"Aloisi","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2020.106199_b0215","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1016\/j.cellsig.2013.08.031","article-title":"G protein-coupled receptor kinase 2 (GRK2) is a Rho-activated scaffold protein for the ERK MAP kinase cascade","volume":"25","author":"Robinson","year":"2013","journal-title":"Cell Signal."},{"key":"10.1016\/j.intimp.2020.106199_b0220","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41401-018-0169-5","article-title":"Paeoniflorin-6 -O-benzene sulfonate alleviates collagen induced arthritis in mice by downregulating BAFF-TRAF2-NF-\u03baB signaling: comparison with biological agents","volume":"40","author":"Shu","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2020.106199_b0225","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3389\/fphar.2017.00933","article-title":"CP-25, a Novel Anti-inflammatory and Immunomodulatory Drug, Inhibits the Functions of Activated Human B Cells through Regulating BAFF and TNF-alpha Signaling and Comparative Efficacy with Biological Agents","volume":"8","author":"Zhang","year":"2017","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.intimp.2020.106199_b0230","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.cub.2006.08.083","article-title":"Phosphorylation of p38 by GRK2 at the docking groove unveils a novel mechanism for inactivating p38MAPK","volume":"16","author":"Peregrin","year":"2006","journal-title":"Curr. Biol."},{"key":"10.1016\/j.intimp.2020.106199_b0235","first-page":"4831","article-title":"CP-25 exerts anti-angiogenic effects on a rat model of adjuvant-induced arthritis by promoting GRK2-induced downregulation of CXCR4-ERK1\/2 signaling in endothelial cells","volume":"20","author":"Zhang","year":"2019","journal-title":"Mol. Med. Rep."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691932613X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691932613X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:43:20Z","timestamp":1762551800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757691932613X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":47,"alternative-id":["S156757691932613X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106199","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alleviating effect of paeoniflorin-6\u2032-O-benzene sulfonate in antigen-induced experimental Sj\u00f6gren\u2019s syndrome by modulating B lymphocyte migration via CXCR5-GRK2-ERK\/p38 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106199"}}